Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(Rac)-Etavopivat ((Rac)-FT-4202), an isomer of Etavopivat, is an orally active activator of erythrocyte pyruvate kinase-R (PKR) used in studies related to sickle cell disease and other haemoglobinopathies [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | (Rac)-Etavopivat ((Rac)-FT-4202), an isomer of Etavopivat, is an orally active activator of erythrocyte pyruvate kinase-R (PKR) used in studies related to sickle cell disease and other haemoglobinopathies [1]. |
Synonyms | (Rac)-FT-4202 |
Molecular Weight | 457.5 |
Formula | C22H23N3O6S |
CAS No. | 2622070-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Rac)-Etavopivat 2622070-93-1 FT 4202 Etavopivat FT4202 FT-4202 (Rac)-FT-4202 inhibitor inhibit